Effect of 2 Interventions on Cervical Cancer Screening Guideline Adherence

被引:4
|
作者
Moscicki, Anna-Barbara [1 ]
Chang, Charlene [1 ]
Vangala, Sitaram [2 ]
Zhou, Xinkai [2 ]
Elashoff, David A. [2 ]
Dehlendorf, Christine [3 ]
Sawaya, George F. [4 ]
Kuppermann, Miriam [4 ,5 ]
Duron, Ysabel [6 ]
Wyand, Fred L. [7 ]
Navarro, Sandy K. [8 ]
de Bocanegra, Heike Thiel [9 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Med, Stat Core, Sch Med, Los Angeles, CA 90095 USA
[3] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA USA
[4] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[6] Latina Canc Inst, San Jose, CA USA
[7] Amer Sexual Hlth Assoc, Natl Cerv Canc Coalit, Res Triangle Pk, NC USA
[8] Univ Calif Davis Hlth, Hlth Informat, Davis, CA USA
[9] Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92717 USA
关键词
HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA; NATURAL-HISTORY; REGRESSION; WOMEN; PAP; OUTCOMES; LESIONS; RISKS;
D O I
10.1016/j.amepre.2020.11.015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: This study sought to determine whether a provider mobile phone application, used with or without a patient educational tool accessed on a computer tablet, would promote adher-ence to guidelines for cervical cancer screening and management of abnormal cytology in young women. Methods: The study was conducted as a prospective cohort study in which 14 Family Planning, Access, Care, and Treatment provider clinics were randomized to 1 of 2 arms: (1) provider mobile phone application only or (2) provider mobile phone application plus patient educational tool. The provider mobile phone application gave information to providers regarding cervical cancer screen -ing and management of abnormal cytology. The patient educational tool accessed on a computer tablet was a patient-centered educational tool. Each arm was compared with clinic control groups (no intervention) in a 2:1 ratio (control:intervention). Claims data were used to calculate and com-pare 18-month cytology (Pap) and colposcopy rates before the intervention and during the 18 months using the Poisson mixed-effect regression model. A sensitivity analysis examined the differ-ences in the rate of change between each arm and controls. The study took place between July 2015 and December 2016, and analysis was performed in 2019. Results: The clinics randomized to the provider mobile phone application plus patient educational tool arm and their control group achieved similar 18-month Pap rates (0.52, 95% CI=0.37, 0.74 and 0.68, 95% CI=0.53, 0.86, respectively) as well as the provider mobile phone application arm and their control group (0.44, 95% CI=0.33, 0.58 and 0.41, 95% CI=0.34, 0.51; p-values >0.1). In the sensitivity analysis, the difference in the rate of change in Pap rates for the provider mobile phone application plus patient educational tool arm and their control group before and during the inter-vention was -0.22 and -0.09, respectively (p=0.02), but no differences were seen between the pro -vider mobile phone application arm and their control group. No significant changes were observed for colposcopy rates. Conclusions: Providing clinicians and patients with information on guidelines had no demonstra-ble effect on 18-month Pap and colposcopy rates in the regression model; however, results from the sensitivity analysis for the patient educational tool were encouraging. (C) 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:666 / 673
页数:8
相关论文
共 50 条
  • [21] Adherence to cervical cancer screening in an Italian SLE cohort
    Tani, C.
    Carli, L.
    Mosca, M.
    Baldini, C.
    Consensi, A.
    Doveri, M.
    Talarico, R.
    Bombardieri, S.
    REUMATISMO, 2011, 63 (01) : 11 - 17
  • [22] Adherence to Guideline-Recommended cancer screening among Utah cancer survivors
    Millar, Morgan M.
    Edwards, Sandra L.
    Herget, Kimberly A.
    Orleans, Brian
    Ofori-Atta, Blessing S.
    Kirchhoff, Anne C.
    Carter, Marjorie E.
    Nagata, Marie
    Sweeney, Carol
    CANCER MEDICINE, 2023, 12 (03): : 3543 - 3554
  • [23] Cervical cancer screening among vulnerable women Factors affecting guideline adherence at a community health centre in Toronto, Ont
    Wiedmeyer, Mei-ling
    Lofters, Aisha
    Rashid, Meb
    CANADIAN FAMILY PHYSICIAN, 2012, 58 (09) : E521 - E526
  • [24] Cervical Cancer Screening in Botswana: An Urgent Call for Guideline Change
    Bhatia, R.
    Ramogola-Masire, D.
    Friebel-Klingner, T.
    Monare, B.
    Grover, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S119 - S120
  • [25] Breast and cervical cancer screening interventions: An assessment of the literature
    Meissner, HI
    Breen, N
    Coyne, C
    Legler, JM
    Green, DT
    Edwards, BK
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (10) : 951 - 961
  • [26] Cervical cancer screening in Malaysia: Are targeted interventions necessary?
    Dunn, Richard A.
    Tan, Andrew K. G.
    SOCIAL SCIENCE & MEDICINE, 2010, 71 (06) : 1089 - 1093
  • [27] Disparities in colorectal cancer screening: A guideline-based analysis of adherence
    James, TM
    Greiner, KA
    Ellerbeck, EF
    Feng, CY
    Ahluwalia, JS
    ETHNICITY & DISEASE, 2006, 16 (01) : 228 - 233
  • [28] SURVIVORSHIP CARE PLANNING AND ADHERENCE TO GUIDELINE-RECOMMENDED CANCER SCREENING
    Shay, L. Aubree
    Dioun, Shayda I.
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S2437 - S2438
  • [29] BEHAVIORAL INTERVENTIONS TO INCREASE ADHERENCE IN COLORECTAL-CANCER SCREENING
    MYERS, RE
    ROSS, EA
    WOLF, TA
    BALSHEM, A
    JEPSON, C
    MILLNER, L
    MEDICAL CARE, 1991, 29 (10) : 1039 - 1050
  • [30] Insurance and adherence to guideline concordant cervical cancer therapy do not reduce mortality?
    Brewster, Wendy R.
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : 297 - 298